On the impact of the CYP2D6 ultra-rapid metabolizer genotype on mirtazapine pharmacokinetics.

被引：0
|
作者：
Brockmöller, J
Kirchheiner, J
Henckel, H
Meineke, I
Roots, I
机构：
[1] Univ Gottingen, D-3400 Gottingen, Germany
[2] Humboldt Univ, D-1086 Berlin, Germany
[3] Charite Med Ctr, Berlin, Germany
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2004年 / 75卷 / 02期
关键词：
D O I：
10.1016/j.clpt.2003.11.250
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P67 / P67
页数：1
相关论文
共 50 条
  • [11] Metoprolol pharmacokinetics and pharmacodynamics in carriers of CYP2D6 genotypes predicting ultra-rapid metabolism.
    Kirchheiner, J
    Meisel, C
    Heesch, C
    Bauer, S
    Keulen, T
    Henckel, H
    Roots, I
    Brockmöller, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (02) : P19 - P19
  • [12] Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication
    J Kirchheiner
    H Schmidt
    M Tzvetkov
    J-Tha Keulen
    J Lötsch
    I Roots
    J Brockmöller
    The Pharmacogenomics Journal, 2007, 7 : 257 - 265
  • [13] Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication
    Kirchheiner, J.
    Schmidt, H.
    Tzvetkov, M.
    Keulen, J-Tha
    Loetsch, J.
    Roots, I.
    Brockmoeller, J.
    PHARMACOGENOMICS JOURNAL, 2007, 7 (04): : 257 - 265
  • [14] Impact of the intermediate metabolizer CYP2D6 genotype on amitriptyline and nortriptyline plasma levels
    Steimer, W
    Zöpf, K
    Bachofer, J
    von Amelunxen, S
    Pfeiffer, H
    Müller, B
    Kissling, W
    Leucht, S
    THERAPEUTIC DRUG MONITORING, 2003, 25 (04) : 528 - 528
  • [15] Correlation of CYP2D6 genotype with perhexiline phenotypic metabolizer status
    Barclay, ML
    Sawyers, SM
    Begg, EJ
    Zhang, M
    Roberts, RL
    Kennedy, MA
    Elliott, JM
    PHARMACOGENETICS, 2003, 13 (10): : 627 - 632
  • [16] Impact of CYP2D6 intermediate metabolizer alleles on single-dose desipramine pharmacokinetics
    Furman, KD
    Grimm, DR
    Mueller, T
    Holley-Shanks, RR
    Bertz, RJ
    Williams, LA
    Spear, BB
    Katz, DA
    PHARMACOGENETICS, 2004, 14 (05): : 279 - 284
  • [17] Enantiospecific pharmacokinetics of metoprolol in CYP2D6 ultra-rapid metabolizers and correlation with exercise-induced heart rate
    Seeringer, Angela
    Brockmoeller, Juergen
    Bauer, Steffen
    Kirchheiner, Julia
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 64 (09) : 883 - 888
  • [18] Enantiospecific pharmacokinetics of metoprolol in CYP2D6 ultra-rapid metabolizers and correlation with exercise-induced heart rate
    Angela Seeringer
    Jürgen Brockmöller
    Steffen Bauer
    Julia Kirchheiner
    European Journal of Clinical Pharmacology, 2008, 64
  • [19] High Frequency of CYP2D6 Ultrarapid Metabolizer Genotype in the Finnish Population
    Pietarinen, Paavo
    Tornio, Aleksi
    Niemi, Mikko
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2016, 119 (03) : 291 - 296
  • [20] Variability in the pharmacokinetics of R-(-)- and S-(+)-mirtazapine in dependence of the CYP2D6 genotype.
    Kirchheiner, JC
    Henckel, HB
    Meineke, I
    Roots, I
    Brockmöller, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P26 - P26
12345